← GLOBUS MEDICAL INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $564.0m |
$636.0m
+12.76%
|
$713.0m
+12.11%
|
$785.4m
+10.15%
|
$789.0m
+0.47%
|
$958.1m
+21.43%
|
$1.0b
+6.76%
|
$1.6b
+53.34%
|
$2.5b
+60.62%
|
$2.9b
+16.65%
|
$3.1b
+7.01%
|
|
| Cost of Revenue | $134.7m |
$150.5m
+11.69%
|
$159.4m
+5.95%
|
$180.0m
+12.90%
|
$217.5m
+20.83%
|
$239.2m
+10.01%
|
$263.7m
+10.24%
|
$548.2m
+107.86%
|
$1.0b
+88.90%
|
$957.8m
-7.50%
|
$989.1m
+3.27%
|
|
| Gross Profit | $429.3m |
$485.5m
+13.10%
|
$553.6m
+14.01%
|
$605.4m
+9.36%
|
$571.6m
-5.59%
|
$718.9m
+25.77%
|
$759.1m
+5.60%
|
$1.0b
+34.41%
|
$1.5b
+45.43%
|
$2.0b
+33.51%
|
$2.2b
+8.82%
|
|
| Interest Income (Expense), Net | $3.1m |
$6.6m
+116.16%
|
$13.3m
+100.94%
|
$17.4m
+31.09%
|
$14.0m
-19.84%
|
$9.3m
-33.36%
|
$14.2m
+53.09%
|
$20.1m
+41.43%
|
($4.2m)
-120.81%
|
$7.1m
+270.47%
|
— | |
| Research and Development Expense | $44.5m | $43.7m | $55.5m | $60.1m | $84.5m | $97.3m | $73.0m | $124.0m | $163.8m | $147.2m | $147.1m | |
| Selling, General and Administrative Expense | $222.2m | $267.8m | $311.6m | $354.8m | $354.8m | $408.1m | $432.1m | $643.4m | $981.0m | $1.2b | $1.2b | |
| Amortization of Intangible Assets | $3.5m | $7.9m | $9.6m | $13.8m | $16.8m | $18.5m | $17.7m | $51.0m | $119.4m | $118.2m | — | |
| Operating Lease, Expense | — | — | — | $3.2m | $3.6m | $3.4m | — | — | — | — | — | |
| Restructuring Costs | — | — | — | — | — | — | — | $0 | $23.8m | $15.0m | — | |
| Operating Expenses | $275.1m | $323.7m | $384.2m | $433.4m | $460.1m | $546.9m | $531.2m | $887.2m | — | — | $2.5b | |
| Operating Income (Loss) | $154.1m |
$161.8m
+4.99%
|
$169.3m
+4.62%
|
$172.0m
+1.57%
|
$111.4m
-35.21%
|
$172.0m
+54.31%
|
$228.0m
+32.57%
|
$133.1m
-41.59%
|
$166.0m
+24.67%
|
$479.8m
+189.06%
|
$673.8m
+40.42%
|
|
| Foreign Currency Transaction Gain (Loss), before Tax | ($482k) | $909k | $360k | $75k | ($279k) | ($1.4m) | ($1.0m) | $14.3m | ($43.3m) | ($3.0m) | — | |
| Gain (Loss) on Derivative Instruments, Net, Pretax | — | — | — | — | — | — | — | $14.1m | ($43.3m) | ($3.0m) | — | |
| Other Nonoperating Income (Expense) | $3.1m | $8.1m | $19.3m | $18.0m | $14.5m | $8.5m | $15.1m | $32.3m | $2.2m | $3.4m | — | |
| Interest Income (Expense), Nonoperating, Net | — | — | — | — | — | — | — | — | — | $7.1m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $154.4m | $155.1m | $180.7m | $179.2m | $154.4m | $184.8m | $247.3m | $181.8m | $149.5m | $586.5m | $660.1m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | — | — | $180.4m | $243.0m | $165.4m | $120.7m | $605.1m | $660.1m | |
| Current Income Tax Expense (Benefit) | $57.1m | $54.4m | $31.2m | $30.4m | $27.6m | $48.9m | $75.2m | $100.8m | $151.8m | — | $124.7m | |
| Income Tax Expense (Benefit) | $52.9m | $62.6m | $32.1m | $34.7m | $23.6m | $31.2m | $52.9m | $42.5m | $17.7m | $67.2m | $124.7m | |
| Net Income (Loss) Attributable to Parent | $104.3m |
$107.3m
+2.88%
|
$156.5m
+45.76%
|
$155.2m
-0.81%
|
$102.3m
-34.10%
|
$149.2m
+45.86%
|
$190.2m
+27.47%
|
$122.9m
-35.39%
|
$103.0m
-16.19%
|
$537.9m
+422.28%
|
$535.4m
-0.45%
|
|
| Earnings Per Share, Basic | $1.09 | $1.12 | $1.60 | $1.57 | $1.04 | $1.48 | $1.89 | $1.09 | $0.76 | $3.98 | $3.97 | |
| Earnings Per Share, Diluted | $1.08 | $1.10 | $1.54 | $1.52 | $1.01 | $1.44 | $1.85 | $1.07 | $0.75 | $3.92 | $3.91 | |
| Weighted Average Number of Shares Outstanding, Basic | 95.6m | 96.2m | 97.9m | 99.2m | 98.6m | 100.7m | 100.5m | 113.1m | 135.7m | 135.2m | 134.8m | |
| Weighted Average Number of Shares Outstanding, Diluted | 96.4m | 97.9m | 101.3m | 102.0m | 101.0m | 103.6m | 102.6m | 114.6m | 137.9m | 137.1m | 136.9m | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | $1.8m | $1.6m | $1.7m | $2.6m | $4.0m | $17.0m | $6.0m | $68.3m | $29.6m | $42.3m | — | |
| Goodwill, Impairment Loss | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Share-based Payment Arrangement, Expensed and Capitalized, Amount | $11.7m | $14.9m | $22.2m | $26.4m | $27.3m | $31.3m | $33.5m | $52.8m | $54.3m | $76.5m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.